These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2838217)
21. In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis. Coudron PE; Johnston JL; Archer GL J Antimicrob Chemother; 1987 Oct; 20(4):505-11. PubMed ID: 2824426 [TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of LY146032 against Staphylococcus aureus, Listeria monocytogenes, Corynebacterium JK, and Bacillus spp., in comparison with various antibiotics. Van der Auwera P; Grenier P; Klastersky J J Antimicrob Chemother; 1987 Aug; 20(2):209-12. PubMed ID: 2822648 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid). Ling TK; Fung KS; Cheng AF Chemotherapy; 2001; 47(4):243-9. PubMed ID: 11399860 [TBL] [Abstract][Full Text] [Related]
24. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections. Wagenlehner FM; Lehn N; Witte W; Naber KG Chemotherapy; 2005 May; 51(2-3):64-9. PubMed ID: 15870498 [TBL] [Abstract][Full Text] [Related]
25. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies. Stratton CW; Weeks LS Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634 [TBL] [Abstract][Full Text] [Related]
29. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. Rand KH; Houck H J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062 [TBL] [Abstract][Full Text] [Related]
30. In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococci. Watanakunakorn C J Antimicrob Chemother; 1987 Apr; 19(4):445-8. PubMed ID: 3034849 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria. Debbia E; Pesce A; Schito GC Antimicrob Agents Chemother; 1988 Feb; 32(2):279-81. PubMed ID: 2834999 [TBL] [Abstract][Full Text] [Related]
32. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp. Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT Antimicrob Agents Chemother; 2004 Jun; 48(6):2149-52. PubMed ID: 15155214 [TBL] [Abstract][Full Text] [Related]
34. Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin. Van der Auwera P; Van Laethem Y; Klastersky J J Antimicrob Chemother; 1987 Aug; 20(2):239-49. PubMed ID: 3478329 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of ciprofloxacin against gram-positive cocci. Barry AL; Jones RN Am J Med; 1987 Apr; 82(4A):27-32. PubMed ID: 3578323 [TBL] [Abstract][Full Text] [Related]
36. Comparison of daptomycin MIC results by DIN, NCCLS, SFM, and SRGA methods for 297 Gram-positive organisms. Koeth LM; Leclercq R; Olsson-Liljequist B Int J Antimicrob Agents; 2004 Jan; 23(1):17-24. PubMed ID: 14732309 [TBL] [Abstract][Full Text] [Related]
37. Activity of LY146032 against Enterococci with and without high-level aminoglycoside resistance, including two penicillinase-producing strains. Wanger AR; Murray BE Antimicrob Agents Chemother; 1987 Nov; 31(11):1779-81. PubMed ID: 2829715 [TBL] [Abstract][Full Text] [Related]
38. In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria. Eliopoulos GM; Reiszner E; Moellering RC Antimicrob Agents Chemother; 1985 Jan; 27(1):28-32. PubMed ID: 3845792 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of LY146032 (daptomycin), a new peptolide. Ehlert F; Neu HC Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611 [TBL] [Abstract][Full Text] [Related]
40. Antimicrobial interactions (synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against gram-positive isolates from Germany and the United States. Jones RN; Marshall SA; Grimm H Diagn Microbiol Infect Dis; 1997 Oct; 29(2):87-94. PubMed ID: 9368084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]